Stock Information
Apogee Therapeutics Inc (APGE)
Ticker Symbol: APGE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,849.96 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -4.3314
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -32.64%
Latest News
-
U.S. Equity Markets: Lots Of Gambling Going On
Tue, Jun 30, 2026 11:55 AM
-
Biotech Is The Rate Cut Trade In Disguise
Mon, Jun 29, 2026 5:20 PM
-
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
Mon, Jun 29, 2026 5:00 PM
-
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic Bankruptcy
Fri, Jun 26, 2026 1:52 PM
-
Stifel Downgrades Apogee Therapeutics to Hold, Raises Price Target to $135
Wed, Jun 24, 2026 10:59 AM
-
TD Cowen Downgrades Apogee Therapeutics to Hold
Wed, Jun 24, 2026 10:24 AM
-
Guggenheim Downgrades Apogee Therapeutics to Neutral
Wed, Jun 24, 2026 9:38 AM
-
Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Wed, Jun 24, 2026 8:56 AM
-
This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Wed, Jun 24, 2026 8:17 AM
-
Mizuho Downgrades Apogee Therapeutics to Neutral, Raises Price Target to $135
Wed, Jun 24, 2026 5:54 AM
Key Financials
Financial data not available
